News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
244,007 Results
Type
Article (7842)
Company Profile (55)
Press Release (236109)
Multimedia
Podcasts (7)
Webinars (2)
Section
Business (72560)
Career Advice (231)
Deals (15811)
Drug Delivery (15)
Drug Development (31027)
Employer Resources (13)
FDA (5211)
Job Trends (5468)
News (123417)
Policy (10721)
Tag
2027 Pharm Country Standard (1)
Academia (814)
Accelerated approval (22)
ADA (14)
Adcomms (1)
Allergies (56)
Alliances (12313)
ALS (68)
Alzheimer's disease (680)
Antibody-drug conjugate (ADC) (170)
Approvals (5557)
Artificial intelligence (157)
ASCO (164)
Autoimmune disease (102)
Automation (17)
Bankruptcy (120)
Best Places to Work (4985)
BIOSECURE Act (3)
Biosimilars (29)
Biotechnology (33)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (312)
Cancer (2352)
Cardiovascular disease (177)
Career advice (209)
Career pathing (4)
CAR-T (115)
CDC (5)
Celiac Disease (1)
Cell therapy (283)
Cervical cancer (19)
Clinical research (28062)
Collaboration (495)
Company closure (2)
Compensation (339)
Complete response letters (20)
COVID-19 (1207)
CRISPR (32)
C-suite (227)
Cystic fibrosis (52)
Data (3711)
Decentralized trials (1)
Denatured (1)
Depression (87)
Dermatology (40)
Diabetes (214)
Diagnostics (2572)
Digital health (21)
Diversity, equity & inclusion (1)
Drug discovery (69)
Drug pricing (12)
Drug shortages (3)
Duchenne muscular dystrophy (89)
Earnings (48635)
Editorial (11)
Employer branding (3)
Employer resources (13)
Events (41290)
Executive appointments (215)
FDA (6792)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (11)
Frontotemporal dementia (15)
Funding (360)
Gene editing (62)
Generative AI (5)
Gene therapy (160)
GLP-1 (299)
Government (1632)
Grass and pollen (3)
Guidances (339)
Healthcare (7588)
Hematology (71)
HIV (31)
Huntington's disease (15)
IgA nephropathy (33)
Immunology and inflammation (76)
Immuno-oncology (26)
Indications (85)
Infectious disease (1326)
Inflammatory bowel disease (84)
Influenza (47)
Intellectual property (103)
Interviews (38)
IPO (10431)
IRA (3)
Job creations (681)
Job search strategy (179)
JPM (9)
Kidney cancer (7)
Labor market (27)
Layoffs (112)
Leadership (5)
Legal (2074)
Liver cancer (37)
Longevity (14)
Lung cancer (333)
Lymphoma (196)
Machine learning (14)
Management (5)
Manufacturing (227)
MASH (98)
Medical device (5613)
Medtech (5653)
Mergers & acquisitions (5859)
Metabolic disorders (514)
mRNA (42)
Multiple sclerosis (63)
NASH (10)
Neurodegenerative disease (154)
Neuropsychiatric disorders (30)
Neuroscience (1197)
NextGen: Class of 2026 (1716)
Non-profit (1371)
Now hiring (8)
Obesity (197)
Opinion (24)
Ovarian cancer (104)
Pain (77)
Pancreatic cancer (134)
Parkinson's disease (109)
Partnered (8)
Patents (183)
Patient recruitment (179)
Peanut (23)
People (14660)
Pharmaceutical (12)
Pharmacy benefit managers (4)
Phase 1 (7937)
Phase 2 (12258)
Phase 3 (10453)
Pipeline (4660)
Policy (28)
Postmarket research (889)
Preclinical (2937)
Press Release (15)
Prostate cancer (115)
Psychedelics (7)
Radiopharmaceuticals (139)
Rare diseases (345)
Real estate (1252)
Recruiting (7)
Regulatory (8903)
Reports (11)
Research institute (657)
Resumes & cover letters (23)
Rett syndrome (12)
RNA editing (5)
RSV (35)
Schizophrenia (83)
Series A (55)
Series B (44)
Service/supplier (6)
Sickle cell disease (38)
Special edition (10)
Spinal muscular atrophy (84)
Sponsored (8)
Startups (676)
State (1)
Stomach cancer (1)
Supply chain (33)
Tariffs (12)
The Weekly (6)
Vaccines (308)
Venture capital (24)
Weight loss (107)
Women's health (31)
Worklife (2)
Date
Last 7 days (180)
Last 30 days (939)
Last 365 days (10986)
2026 (5287)
2025 (11239)
2024 (13243)
2023 (15223)
2022 (18850)
2021 (20144)
2020 (41845)
2019 (15551)
2018 (10707)
2017 (10567)
2016 (8599)
2015 (11218)
2014 (7529)
2013 (5238)
2012 (6057)
2011 (6579)
2010 (5737)
Location
Africa (153)
Alabama (38)
Alaska (1)
Arizona (105)
Arkansas (1)
Asia (14717)
Australia (2164)
California (5335)
Canada (1143)
China (497)
Colorado (264)
Connecticut (276)
Delaware (214)
Europe (30477)
Florida (813)
Georgia (135)
Idaho (11)
Illinois (408)
India (16)
Indiana (286)
Iowa (4)
Japan (207)
Kansas (78)
Kentucky (11)
Louisiana (29)
Maine (34)
Maryland (584)
Massachusetts (3373)
Michigan (114)
Minnesota (256)
Mississippi (1)
Missouri (78)
Montana (8)
Nebraska (6)
Nevada (31)
New Hampshire (26)
New Jersey (1710)
New Mexico (7)
New York (1427)
North Carolina (497)
North Dakota (6)
Northern California (2709)
Ohio (129)
Oklahoma (2)
Oregon (6)
Pennsylvania (1136)
Puerto Rico (2)
Rhode Island (5)
South America (273)
South Carolina (14)
Southern California (2173)
Tennessee (39)
Texas (883)
United States (18448)
Utah (139)
Virginia (137)
Washington D.C. (7)
Washington State (371)
West Virginia (1)
Wisconsin (26)
244,007 Results for "21".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biodesix to Participate in Upcoming Investor Conferences - May 21, 2026
May 21, 2026
·
1 min read
Press Releases
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences - May 21, 2026
May 22, 2026
·
1 min read
Press Releases
AlzeCure Pharma to Present at ABG Investor Days on May 21
May 13, 2026
·
2 min read
Press Releases
SpyGlass Pharma to Participate in Upcoming Investor Conferences - May 21, 2026
May 21, 2026
·
1 min read
Press Releases
Oligonucleotide CDMO Market Worth $6.73 Billion by 2029, Growing at 21.8% CAGR
June 10, 2026
·
1 min read
Press Releases
AlzeCure Pharma to Present at Redeye Investor Forum Online on May 21
May 13, 2026
·
2 min read
Press Releases
Zealand Pharma - Transactions related to share buy-back program (week 21, 2026)
May 26, 2026
·
3 min read
Press Releases
Zai Lab Announces Changes to Senior Leadership Team - May 21, 2026
May 22, 2026
·
4 min read
Press Releases
First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences - May 21, 2026
May 22, 2026
·
1 min read
Press Releases
Enpro to Present at Oppenheimer 21st Annual Industrial Growth Conference
April 30, 2026
·
1 min read
1 of 24,401
Next
